SUBSCRIBE
SUBSCRIBE
News   FDA

India’s Sun Pharmaceutical Industries Ltd Gets US Nod to Sell Cancer Drug

September 23, 2008 | 
1 min read
NEW DELHI, Sept 23 (Reuters) - India's Sun Pharmaceutical Industries said on Tuesday it had approval from the U.S. Food and Drug Administration to market generic versions of Paraplatin, which is indicated for the treatment of ovarian cancer.
FDA Approvals Asia
MORE ON THIS TOPIC
Racing Cars at the finish line
Approvals
Ascendis Enters Achondroplasia Arena as FDA Approves First Weekly Drug
March 2, 2026
 · 
2 min read
 · 
Tristan Manalac
A scientist with pill bottles in front of FDA headquarters
Regulatory
FDA Action Alert: BMS, GSK, Aldeyra and More
March 2, 2026
 · 
4 min read
 · 
Tristan Manalac
Borrow money from friend, debt and loan, incentive or bonus payment, credit or lending concept, businessman hand giving money banknote to friend's hand.
FDA
FDA To Offer Bonus Payments for Speedy Drug Reviewers
February 27, 2026
 · 
1 min read
 · 
Annalee Armstrong
Female hand showing thumbs up gesture on blue background, art collage. Positive hand sign. Fashion collage in the style of Thumbs up magazine. Contemporary art. Modern design.
Approvals
Boehringer Wins Speedy Lung Cancer Approval Under Commissioner’s Priority Program
February 27, 2026
 · 
2 min read
 · 
Tristan Manalac